ES2058793T3 - Material compuesto de pantotenato calcico. - Google Patents

Material compuesto de pantotenato calcico.

Info

Publication number
ES2058793T3
ES2058793T3 ES90304169T ES90304169T ES2058793T3 ES 2058793 T3 ES2058793 T3 ES 2058793T3 ES 90304169 T ES90304169 T ES 90304169T ES 90304169 T ES90304169 T ES 90304169T ES 2058793 T3 ES2058793 T3 ES 2058793T3
Authority
ES
Spain
Prior art keywords
calcium pantothenate
ingredients
composite
stable
composite material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90304169T
Other languages
English (en)
Inventor
Junzou Yamashita
Yasuo Ono
Kunihiko Sumimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2058793T3 publication Critical patent/ES2058793T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)

Abstract

UN COMPUESTO EL CUAL ES OBTENIBLE MEZCLANDO PANTOTENATO DE CALCIO CON UN LACTATO O CARBONATO DE CALCIO O DE MAGNESIO BASICO O NEUTRAL POR SI MISMO, EN PRESENCIA DE AGUA Y/O UN ALCOHOL INFERIOR, Y SECANDO LA MEZCLA RESULTANTE, ES ESTABLE SIN QUE SE REDUZCA EL CONTENIDO DE PANTOTENATO CALCICO DURANTE EL ALMACENAMIENTO. CUANDO OTRAS DROGAS, LAS CUALES PUEDEN CAUSAR CAMBIOS COMO RESULTADO DE COMBINACION CON PANTOTENATO CALCICO, SE COMBINAN PARA PRODUCIR VARIOS PREPARADOS, LOS COMPUESTOS SON ESTABLES PORQUE SON DIFICILMENTE AFECTADOS POR OTROS INGREDIENTES Y DIFICILMENTE AFECTAN A OTROS INGREDIENTES; POR EJEMPLO, EN PRODUCCION DE TABLETAS, POLVOS, GRANULOS, Y CAPSULAS, NO SE REQUIEREN COMPLICADOS PROCESOS PARA SEPARARLE DE OTROS INGREDIENTES, Y SE PUEDE REDUCIR DE FORMA IMPORTANTE LA EXCESIVA CANTIDAD PERDIDA CON EL TIEMPO DE LOS PROCEDIMIENTOS CONOCIDOS.
ES90304169T 1989-04-19 1990-04-19 Material compuesto de pantotenato calcico. Expired - Lifetime ES2058793T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9963789 1989-04-19
JP17944089 1989-07-11

Publications (1)

Publication Number Publication Date
ES2058793T3 true ES2058793T3 (es) 1994-11-01

Family

ID=26440747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90304169T Expired - Lifetime ES2058793T3 (es) 1989-04-19 1990-04-19 Material compuesto de pantotenato calcico.

Country Status (8)

Country Link
US (1) US5089276A (es)
EP (1) EP0394022B1 (es)
JP (1) JP2891744B2 (es)
AT (1) ATE91412T1 (es)
DE (1) DE69002186T2 (es)
DK (1) DK0394022T3 (es)
ES (1) ES2058793T3 (es)
HU (1) HU208626B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2252905B (en) * 1991-02-11 1995-05-10 Leung Lit Hung An agent for correcting a deficiency of androgenic steroids
CA2356166A1 (en) 1998-12-25 2000-07-06 Motoo Shiba Method for producing calcium pantothenate
US8232081B2 (en) * 1999-09-21 2012-07-31 Basf Se Methods and microorganisms for production of panto-compounds
US6509496B1 (en) 2000-10-19 2003-01-21 Nutrapure, Inc. Process for making mineral, food or pharmaceutical grade salt products
US6887492B2 (en) 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
JP4841130B2 (ja) * 2004-10-12 2011-12-21 武田薬品工業株式会社 安定化されたビタミン製剤
JP4615470B2 (ja) 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
ES2379969T3 (es) 2007-07-06 2012-05-07 Basf Se Proceso para la producción de una solución de glucosa acuosa a partir de maíz
DE112008001983B4 (de) * 2007-07-31 2023-08-10 Dsm Ip Assets B.V. Verfahren für die Synthese von Na-beta-Alaninat
JP5524130B2 (ja) * 2011-05-19 2014-06-18 武田薬品工業株式会社 安定化されたビタミン製剤
JPWO2019013234A1 (ja) 2017-07-11 2020-07-02 武田コンシューマーヘルスケア株式会社 ビタミンｂ１類を配合する固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864701A (en) * 1954-04-30 1958-12-16 Merck & Co Inc Stabilized pantothenic acid compositions
US2992273A (en) * 1958-03-12 1961-07-11 Nopco Chem Co Preparation of dense calcium pantothenate
US3092548A (en) * 1960-10-27 1963-06-04 Warren Teed Products Company Method of treating peptic ulcers with pantothenic acid
US3247064A (en) * 1962-03-30 1966-04-19 Shionogi & Co Multivitamin tablet stabilized with porous silica
RO68298A2 (ro) * 1975-08-05 1980-04-15 Intreprinderea De Medicamente,Ro Compozitie pe baza de saruri organice de calciu si magneziu usor asimilabile si cu o solubilitate crescuta,si procedeu de preparare a acesteia

Also Published As

Publication number Publication date
US5089276A (en) 1992-02-18
DK0394022T3 (da) 1993-08-23
JP2891744B2 (ja) 1999-05-17
EP0394022A1 (en) 1990-10-24
HU208626B (en) 1993-12-28
JPH03123729A (ja) 1991-05-27
DE69002186T2 (de) 1994-01-27
EP0394022B1 (en) 1993-07-14
HU902470D0 (en) 1990-08-28
DE69002186D1 (de) 1993-08-19
ATE91412T1 (de) 1993-07-15
HUT54040A (en) 1991-01-28

Similar Documents

Publication Publication Date Title
ES2058793T3 (es) Material compuesto de pantotenato calcico.
NO174062C (no) Fremgangsmåte for fremstilling av blekende granulat, samt anvendelse av granulatet
JPS56144055A (en) Tablet confectionery containing bifidus bacterium and its production
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS55157643A (en) Polymer composition
AU5921380A (en) Preparation of pulping agent
JPS5328693A (en) Polyester polyestier rlow molded articles or other preliminary molded article
JPS6430563A (en) Concentrated and dried juice of plum or watermelon and preparation thereof
JPS5379860A (en) Preparation of 1-acyl-3-indolinone derivs.
JPS52117394A (en) Preparation of polyesters with improved whiteness
JPS5273996A (en) Preparation of polyesters
JPS51148797A (en) Preparation of crosslinked polyester carbonat
JPS5736958A (en) Deodorizing, processing and preparing technique for making krill into food
JPS5363457A (en) Jelly compositions
JPS53101346A (en) Preparation of 5,5'-methylene(2-hhdroxy-4-alkoxybenzoohenone)
JPS53111345A (en) Resin composition
JPS5432487A (en) Preparation of 1-carbamoyluracils
JPS5225118A (en) High shrinkage copolyester fiber and its preparation
JPS6440589A (en) Cold-reserving agent
JPS52142019A (en) Production composition of higher m- and p-diisopropylbenzene content
JPS55108258A (en) Preparation of feed for fish
JPS53119855A (en) Preparation of 4,4'-isopropylydenedicyclohexanol
JPS53127405A (en) Continuous preparation of 1,4-butanediol
JPS54151920A (en) Stabilization of antimony mercaptocarboxylate
JPS5331636A (en) Preparation of aromatic aldehydes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 394022

Country of ref document: ES